Provided by Tiger Fintech (Singapore) Pte. Ltd.

Medtronic PLC

93.07
+0.74000.80%
Post-market: 88.69-4.3751-4.70%16:56 EDT
Volume:7.55M
Turnover:702.63M
Market Cap:119.37B
PE:28.46
High:93.30
Open:92.31
Low:92.12
Close:92.33
Loading ...

The Zacks Analyst Blog Highlights Charles Schwab, Gilead, Medtronic, Cooper-Standard and Rave Restaurant

Zacks
·
26 Feb

Top Stock Reports for Charles Schwab, Gilead Sciences & Medtronic

Zacks
·
26 Feb

Medtronic’s BrainSense brain stimulation system approved by FDA for Parkinson’s

TipRanks
·
25 Feb

Market Chatter: Medtronic Looks to Optimize Global Manufacturing Operations With Trump's Tariff Hit

MT Newswires Live
·
25 Feb

Medtronic explores options to optimize manufacturing operations amid Trump's tariff threats

Reuters
·
25 Feb

Medtronic Executive Ken Washington on U.S. Tariffs Says Co Looking at Ways to Optimize Manufacturing Footprint - Interview

THOMSON REUTERS
·
25 Feb

Truist Financial Remains a Hold on Medtronic (MDT)

TIPRANKS
·
25 Feb

BUZZ-Medtronic rises after FDA approves co's medical tech for Parkinson's disease

Reuters
·
25 Feb

Distributor Purchasing Shifts Mar MDT's Q3 Show: How to Play the Stock

Zacks
·
25 Feb

FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients

Benzinga
·
25 Feb

Medtronic Gets FDA Approval for Deep Brain Stimulation System Treating Parkinson's Disease Symptoms

MT Newswires Live
·
24 Feb

Medtronic Parkinson's Disease Brain Stimulation System Gets FDA Approval

Dow Jones
·
24 Feb

US FDA approves Medtronic's medical device for Parkinson's disease

Reuters
·
24 Feb

Medtronic Earns U.S. FDA Approval for the World's First Adaptive Deep Brain Stimulation System for People With Parkinson's

THOMSON REUTERS
·
24 Feb

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's

PR Newswire
·
24 Feb

The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

Zacks
·
24 Feb